The rise in exclusive deals between insurers and pharmacies
Exclusive deals struck between insurance companies and pharmacies are increasingly drawing scrutiny from patients, pharmacists and cabinet ministers. The arrangements, known as preferred pharmacy networks (PPNs), are meant to deal with rising prices of pharmaceutical drugs. But detractors say these plans mean less transparency, competition and consumer choice. The Globe’s retailing reporter Susan Krashinsky Robertson and wealth management and insurance reporter Clare O’Hara explain why the blowback against PPNs is rooted in questions about who gets to approve treatment for patients.
You May Also Like

Israel Today: Ongoing War Report
Israel Today: Ongoing War Report

The Epstein Chronicles
Bobby Capucci

Bloomberg News Now
Bloomberg

Brian Kilmeade Show
FOX News Podcasts

Durham News Today | 2 Min News | The Daily News Now!
The Daily News Now!

The Situation Room with Wolf Blitzer and Pamela Brown
CNN Podcasts

Ranch It Up Radio Show & Podcast
Jeff ”Tigger” Erhardt & Rebecca ”BEC” Wanner, Tigger & BEC

Armstrong & Getty On Demand
iHeartPodcasts

Aristegui Noticias Podcast
Sonoro, Aristegui

The Zone
Sports Radio 810 WHB
Community discussion